Forex – USD/JPY down during the session in Asia
© Reuters. Forex – USD/JPY down during the session in Asia Investing.com – The u.s. Dollar is + Low as the japanese Yen on Friday. USD/JPY is traded
Forex – GBP/USD up at the end of the session in the United States
Forex – GBP/USD up at the end of the session in the United States Investing.com – The Pound Sterling is higher than the u.s. Dollar this Friday. GBP/USD
Altice barely straighten SFR
In France, Altice has not yet managed to set the bar at SFR. The telecom operator has released, Thursday, November 2, quarterly results, half-tint to its French subsidiary,
The three indices of Wall St ends at a record
© Reuters. WALL STREET ENDS HIGHER by Caroline Valetkevitch NEW YORK (Reuters) – The New York stock Exchange has finished moderate increase on Friday, the good performance of
The flu, a good deal for Sanofi
It is one of the jewels of Sanofi. Built in 1973, the factory, normandy Val-de-Reuil (Eure), is the first site of production of influenza vaccines in the world.
Marvell Technology discusses the redemption of Cavium, reports the Wall Street Journal
© Reuters. Marvell Technology discusses the redemption of Cavium, reports the Wall Street Journal (Reuters) – Marvell Technology is at an advanced stage of discussions to buy its
Forex – USD/JPY up at the end of the session in the United States
Forex – USD/JPY up at the end of the session in the United States Investing.com – The u.s. Dollar is higher than the japanese Yen on Friday. USD/JPY
Currency – The dollar is moving towards employment
© Reuters. The dollar is moving towards employment The dollar has increased slightly on Friday as investors are waiting for u.s. employment. The index dollar, which measures the
The “flat tax” opens up ” capital investment to a wider audience “
Forum. The confirmation of a “flat tax” on capital of 30 % has sparked many reactions in a world of global savings and asset management, which has needed
Nicox: approval of Vyzulta by the FDA
© Reuters. Nicox: approval of Vyzulta by the FDA Bausch + Lomb, subsidiary of Valeant Pharmaceuticals International and Nicox announced the approval by the Food and Drug Administration